Swiss Multiple Sclerosis Registry
NCT02980640 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2025-05-15
Summary
The Swiss Multiple Sclerosis Registry is a national, patient-centered registry with the aim to document the epidemiology of multiple sclerosis (MS), as well as the quality of life of persons living with MS in Switzerland.
Conditions
Sponsors & Collaborators
-
University of Zurich
collaborator OTHER -
Schweizerische Multiple Sklerose Gesellschaft
collaborator OTHER -
Swiss Multiple Sclerosis Registry
lead OTHER
Principal Investigators
-
Milo Puhan, MD PhD · University of Zurich
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2041-06-30
- Completion
- 2041-06-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Study of Empathy in MS
NCT05332951 ·Status: COMPLETED
-
CorEvitas Multiple Sclerosis (MS) Registry
NCT03291756 ·Status: ENROLLING_BY_INVITATION
-
Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2
NCT06309173 ·Status: WITHDRAWN
-
The French Multiple Sclerosis Registry
NCT02889965 ·Status: UNKNOWN
-
Lorraine Registry of Multiple Sclerosis
NCT02883335 ·Status: RECRUITING
-
Metacognition Assessment in Patient With Multiple Sclerosis
NCT04240379 ·Status: COMPLETED
-
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)
NCT06526364 ·Status: RECRUITING
-
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
NCT03369106 ·Status: ACTIVE_NOT_RECRUITING
-
Predicting Disease Activity and Rebound Risk in MS Patients Treated With Sphingosine-1-phosphate Receptor Modulators (S1PRM)
NCT05828901 ·Status: TERMINATED
-
Assessment of Patients With Multiple Sclerosis (MS)
NCT00001156 ·Status: COMPLETED
-
NARCOMS Registry: A Multiple Sclerosis Registry
NCT01018537 ·Status: RECRUITING
-
Multiple Sclerosis Registry in Argentina (RelevarEM)
NCT03375177 ·Status: UNKNOWN
-
Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System
NCT04599023 ·Status: TERMINATED
-
Disability, Perceived Social Support and Quality of Life in Multiple Sclerosis
NCT02880553 ·Status: COMPLETED
-
Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
NCT00220493 ·Status: UNKNOWN ·Phase: PHASE1
-
BrainAgeMS - a Comparative Study of Brain Aging in Healthy and Patients With Multiple Sclerosis
NCT06221631 ·Status: RECRUITING
-
A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.
NCT04760990 ·Status: COMPLETED
-
Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
NCT05177523 ·Status: RECRUITING
-
T-Cell Vaccination in Multiple Sclerosis (MS)
NCT00220428 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC
NCT06095271 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Demographics, Clinical and Paraclinical Characteristics of Multiple Sclerosis in Egypt
NCT02970370 ·Status: COMPLETED
-
Neurocognitive Changes in Patients With Remitting Relapsing Multiple Sclerosis Treated With Natalizumab
NCT01250678 ·Status: UNKNOWN
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
NCT02994121 ·Status: RECRUITING
-
Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study
NCT05285904 ·Status: COMPLETED
-
Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients
NCT05596526 ·Status: RECRUITING ·Phase: PHASE4